当前位置: X-MOL 学术Neuropathol. Appl. Neurobiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Early disease course is unaltered in MPS IIIA mice lacking α‐synuclein
Neuropathology and Applied Neurobiology ( IF 4.0 ) Pub Date : 2019-04-25 , DOI: 10.1111/nan.12548
K Soe 1, 2 , H Beard 1 , D Neumann 1 , P J Trim 1, 2 , S Duplock 1 , M F Snel 1, 2 , J J Hopwood 1, 2 , K M Hemsley 1, 2
Affiliation  

Sanfilippo syndrome (mucopolysaccharidosis type IIIA; MPS IIIA) is an inherited paediatric‐onset neurodegenerative disorder caused by the lysosomal deficiency of sulphamidase with subsequent accumulation of heparan sulphate. The pathological mechanisms responsible for clinical disease are unknown; however, intraneuronal accumulation of aggregation‐prone proteins such as α‐synuclein, phosphorylated tau and amyloid precursor protein suggests inefficient intracellular trafficking and lysosomal degradation.

中文翻译:

缺乏α-突触核蛋白的 MPS IIIA 小鼠的早期病程未改变

Sanfilippo 综合征(粘多糖贮积症 IIIA 型;MPS IIIA)是一种遗传性儿科发病的神经退行性疾病,由溶酶体缺乏磺胺酶并随后积累硫酸乙酰肝素引起。导致临床疾病的病理机制尚不清楚;然而,易于聚集的蛋白质(如 α-突触核蛋白、磷酸化 tau 和淀粉样前体蛋白)的神经元内积累表明细胞内运输和溶酶体降解效率低下。
更新日期:2019-04-25
down
wechat
bug